Frontiers in Endocrinology (Mar 2024)

Appropriate whole genome amplification and pathogenic loci detection can improve the accuracy of preimplantation genetic diagnosis for deletional α-thalassemia

  • Yueyun Lan,
  • Yueyun Lan,
  • Yueyun Lan,
  • Yueyun Lan,
  • Hong Zhou,
  • Hong Zhou,
  • Sheng He,
  • Sheng He,
  • Sheng He,
  • Sheng He,
  • Sheng He,
  • Sheng He,
  • Jinhui Shu,
  • Jinhui Shu,
  • Lifang Liang,
  • Lifang Liang,
  • Lifang Liang,
  • Lifang Liang,
  • Lifang Liang,
  • Hongwei Wei,
  • Hongwei Wei,
  • Hongwei Wei,
  • Hongwei Wei,
  • Hongwei Wei,
  • Hongwei Wei,
  • Jingsi Luo,
  • Jingsi Luo,
  • Jingsi Luo,
  • Jingsi Luo,
  • Caizhu Wang,
  • Caizhu Wang,
  • Xin Zhao,
  • Xin Zhao,
  • Qingming Qiu,
  • Qingming Qiu,
  • Qingming Qiu,
  • Qingming Qiu,
  • Qingming Qiu,
  • Peng Huang,
  • Peng Huang,
  • Peng Huang,
  • Peng Huang,
  • Peng Huang

DOI
https://doi.org/10.3389/fendo.2023.1176063
Journal volume & issue
Vol. 14

Abstract

Read online

ObjectiveTo improve the accuracy of preimplantation genetic testing (PGT) in deletional α-thalassemia patients.DesignArticle.Patient(s)fifty-two deletional α-thalassemia couples.Intervention(s)Whole genome amplification (WGA), Next-generation sequencing (NGS) and PCR mutation loci detection.Main outcome measuresWGA, Single nucleotide polymorphism (SNP) and PCR mutation loci detection results; Analysis of embryo chromosome copy number variation (CNV).ResultsMultiple Displacement Amplification (MDA) and Multiple Annealing and Looping–Based Amplification Cycles (MALBAC) methods for PGT for deletional α-thalassemia. Blastocyst biopsy samples (n = 253) were obtained from 52 deletional α-thalassemia couples. The results of the comparison of experimental data between groups MALBAC and MDA are as follows: (i) The average allele drop-out (ADO) rate, MALBAC vs. MDA = 2.27% ± 3.57% vs. 0.97% ± 1.4%, P=0.451); (ii) WGA success rate, MALBAC vs. MDA = 98.61% vs. 98.89%, P=0.851; (iii) SNP haplotype success rate, MALBAC vs. MDA = 94.44% vs. 96.68%, P=0.409; (iv) The result of SNP haplotype analysis is consistent with that of Gap-PCR/Sanger sequencing results, MALBAC vs. MDA = 36(36/72, 50%) vs. 151(151/181, 83.43%), P=0; (v) Valid SNP loci, MALBAC vs. MDA = 30 ± 9 vs. 34 ± 10, P=0.02; (vi) The mean CV values, MALBAC vs. MDA = 0.12 ± 0.263 vs. 0.09 ± 0.40, P=0.916; (vii) The average number of raw reads, MALBAC vs. MDA =3244259 ± 999124 vs. 3713146 ± 1028721, P=0; (viii) The coverage of genome (%), MALBAC vs. MDA = 5.02 ± 1.09 vs. 5.55 ± 1.49, P=0.008.ConclusionsOur findings indicate that MDA is superior to MALBAC for PGT of deletional α-thalassemia. Furthermore, SNP haplotype analysis combined with PCR loci detection can improve the accuracy and detection rate of deletional α-thalassemia.

Keywords